Publications by authors named "Elodie Jacqueroux"

Claim this Profile
U
Using 99mTc-(V)-DMSA to follow the vascular calcification process in vascular smooth muscle cells based on pit-1 expression.
Pierre-Benoît Bonnefoy, Elodie Jacqueroux, Xavier Delavenne, Frederic Roche, Anthony Clotagatide

Q J Nucl Med Mol Imaging· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro assessment of P-gp and BCRP transporter-mediated drug-drug interactions of riociguat with direct oral anticoagulants.
Elodie Jacqueroux, Clément Mercier, Victor Margelidon-Cozzolino, Sophie Hodin, Laurent Bertoletti

Fundam Clin Pharmacol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of the 3D MucilAir™ nasal model.
Clément Mercier, Elodie Jacqueroux, Zhiguo He, Sophie Hodin, Samuel Constant

Eur J Pharm Biopharm· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Assessment of Pharmacokinetic Drug-Drug Interactions of Direct Oral Anticoagulants: Type 5-Phosphodiesterase Inhibitors Are Inhibitors of Rivaroxaban and Apixaban Efflux by P-Glycoprotein.
Victor Margelidon-Cozzolino, Sophie Hodin, Elodie Jacqueroux, Olivier Delézay, Laurent Bertoletti

J Pharmacol Exp Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition.
Sophie Hodin, Thierry Basset, Elodie Jacqueroux, Olivier Delezay, Anthony Clotagatide

Eur J Drug Metab Pharmacokinet· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis